COLL - Collegium Pharmaceutical Non-GAAP EPS of $1.45 misses by $0.02 revenue of $144.9M misses by $2.04M
2024-05-09 16:16:01 ET
More on Collegium Pharmaceutical
- Collegium Pharmaceutical Q4: The Beat Goes On
- Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript
- Collegium Pharmaceutical, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Collegium Pharmaceutical Q1 2024 Earnings Preview
- Collegium enters authorized generic agreement with Hikma for Nucynta franchise